A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis

Clinical trial NCT05849727 · TERMINATED

Trial details

NCT number: NCT05849727
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2023-08-30
Primary completion: 2025-01-15
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.